Methoxydiglycol is suspected of causing endocrine-disrupting effects, according to European Commission Annex 13. Includes both Category 1 (evidence for endocrine disruption in living organisms) and Category 2 (evidence of potential to cause endocrine disruption in in vitro studies)
Methoxydiglycol has been prohibited for use in cosmetics in Canada.
Methoxydiglycol has been banned for use in cosmetics by the European Union.
It is not on any of GoodGuide’s lists of toxic chemicals which cause suspected or recognized health effects.
It has not been detected in human tissue or urine.